Osteoporosis can present many challenges in clinical practice, particularly in women who have a history of estrogen-sensitive cancers. This is further complicated if they are sensitive to the typical bisphosphonate drugs (Fosamax, Boniva, etc.) that are usually relied upon to treat osteoporosis. Plus, recent evidence is suggesting that these drugs may actually weaken bone strength, actually increasing the risk of fracture.
For women who fit this clinical picture, or simply wish to avoid the risks and side-effects often associated with bisphosphonate drugs, the mineral strontium may be a viable treatment option. In Europe and other parts of the world, strontium (in the form of strontium ranelate) is being prescribed as a reliable treatment for osteoporosis. Among other benefits, it has been shown to enhance the activity of cells that regenerate new bone, reducing the overall risk of fracture in women with osteoporosis and osteopenia.
Other forms of strontium, such as strontium citrate, are just now beginning to undergo clinical trials, but clinical evidence looks promising so far. Talk to your naturopathic physician about whether you are a candidate for strontium or other alternatives to prescription drug therapy for osteoporosis.
